Develop/review a company's Master Validation Plan for significant cGMP deficiencies. Address the U.S. FDA's newer and tougher regulatory stance. One major failing is the lack of sufficient or targeted risk-based V&V planning:
Learning Objectives:-
Agenda:-
Part-1
Part-2
Who will Benefit:-
This seminar will provide valuable assistance to all regulated companies that need to review and modify their Master Validation Planning and Plan(s). While this information is focused on Medical Devices, its principles apply to personnel/companies in the Pharmaceutical, Diagnostic, and Biologics fields. The employees who will benefit include:
Webinarwaves.com is owned and operated by Aabhyasa Inc.